Scorpion Therapeutics competitorsClear all

Scorpion Therapeutics's top competitors include Harpoon Therapeutics, Aeglea, ImmunoGen and Enara Bio.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Scorpion Therapeutics
Scorpion Therapeutics
Scorpion Therapeutics is a company that develops cancer treatments.
Harpoon Therapeutics
Harpoon Therapeutics
Harpoon Therapeutics is a preclinical stage biotechnology company.
Aeglea
Aeglea
Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics.
ImmunoGen
ImmunoGen
ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients.
Enara Bio
Enara Bio
Enara Bio (formerly known as Ervaxx) is a biotech company specializing in the use of Dark Antigens to deliver vaccines and other immunotherapies for treating and preventing cancer.
Founding Date
Founding Date
2020
Founding Date
2015
Founding Date
2013
Founding Date
1981
Founding Date
2016
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Boston, US HQ
Locations
South San Francisco, US HQ
Louisville, US
South San Francisco, US
Locations
Austin, US HQ
Locations
Waltham, US HQ
Locations
Oxford, GB HQ
London, GB
London, GB
Oxford, GB
Employees
Employees
5913% increase
Employees
45
Employees
761% increase
Employees
795% increase
Employees
484% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
252.5 m
Valuation ($)
359.5 m
Valuation ($)
1.1 b
Valuation ($)
N/A
Twitter followers
Twitter followers
124
Twitter followers
N/A
Twitter followers
178
Twitter followers
1 k
Twitter followers
257
Number of tweets (last 30 days)
Number of tweets (last 30 days)
1
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
13
Number of tweets (last 30 days)
4
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
19
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
1.6
Average likes per tweet (last 30 days)
1.3
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
76.92%
Percentage of tweets with engagement (last 30 days)
75%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
344463
Alexa Website Rank
261178
Alexa Website Rank
N/A
Alexa Website Rank
347375
Alexa Website Rank
306818
Employee Rating
Employee Rating
N/A
Employee Rating
4.8
Employee Rating
4.3
Employee Rating
3.3
Employee Rating
5

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$17.4m (FY, 2020)
Revenue (est.)
N/A
Revenue (est.)
$132.3m (FY, 2020)
Revenue (est.)
N/A
Net income
Net income
N/A
Net income
($49.9m) (FY, 2020)
Net income
($80.9m) (FY, 2020)
Net income
($44.4m) (FY, 2020)
Net income
N/A

Funding

Latest funding round
Latest funding round
$ 108m (about 1 year ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 17.5m (about 2 years ago)
Total funding raised
Total funding raised
$ 108m
Total funding raised
$ 130m
Total funding raised
N/A
Total funding raised
$ 56m
Total funding raised
$ 17.5m
For sources of this data, please see the company profile

View company profiles

Harpoon Therapeutics
HQ
South San Francisco, US
Employees
45

Harpoon Therapeutics is a preclinical stage biotechnology company.

View company
Aeglea
HQ
Austin, US
Employees
76↑ 1% increase

Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics.

View company
ImmunoGen
HQ
Waltham, US
Employees
79↑ 5% increase

ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients.

View company
Enara Bio
HQ
Oxford, GB
Employees
48↑ 4% increase

Enara Bio (formerly known as Ervaxx) is a biotech company specializing in the use of Dark Antigens to deliver vaccines and other immunotherapies for treating and preventing cancer.

View company